Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




MRI Technology to Visualize Metabolic Processes in Real Time Could Improve Heart Disease Diagnosis

By HospiMedica International staff writers
Posted on 21 Nov 2022

Magnetic resonance imaging (MRI) has become an indispensable part of medicine. More...

It allows unique insights into the body and diagnosis of various diseases. However, current MRI technology has its limitations: although it can be used to map the structure and function of organs and tissues, it cannot be used to map changes in metabolism, which play a key role in many diseases. However, researchers are now aiming to make that possible by advancing MRI technology so that it can be used to visualize metabolism in real time. The researchers are focusing on the heart, the metabolism of which is particularly complex because it can choose from multiple energy sources. Their new MRI new method to visualize metabolic processes in the body could improve the future diagnosis and treatment of heart disease.

The heart is constantly in motion, which makes imaging a big challenge. Another challenge is that the metabolic molecules are present only in small concentrations – too small to capture with conventional magnetic resonance imaging. Researchers at ETH Zurich (Zurich, Switzerland) and the University of Zurich (Zurich, Switzerland) have succeeded in overcoming these obstacles with the help of hyperpolarized MRI: with it, the researchers can amplify the signal of metabolic molecules by a factor of more than 25,000. The research team adapted hyperpolarized MRI to the specific needs of cardiac and metabolic imaging. The result is a device of the size of a refrigerator operating alongside a clinical MRI machine. The “fridge” certainly lives up to its name: to increase the signal strength, a sugar intermediate (pyruvate) is deep-frozen at −272 degrees Celsius and then magnetized in a magnetic field with the help of microwaves. Once it has been warmed back to body temperature, pyruvate can be used for imaging in a way similar to conventional contrast agents.

This novel method is able to show, non-invasively and in real time, how the heart metabolizes nutrients – in other words, how it converts them into usable energy. While conventional MRI can show whether the heart is pumping and how, the method now also reveals where the heart gets its energy from. To be able to capture and understand this in detail is a major development, especially with regard to heart disease. A problem with metabolism can be an early sign of a heart condition. For example: Under normal circumstances, the heart primarily uses fat as an energy source. If there is a lack of oxygen, however, the heart switches over to sugar as an energy source, as this requires less oxygen to metabolize. If physicians were able to detect such processes by imaging, they could identify a possible oxygen deficiency at an early stage. This would pave the way towards treating the causes of cardiovascular diseases, and not just their effects.

The researchers were able to show that the method they developed does indeed do a good job of visualizing the heart’s metabolism. Pigs were used as a model, as their hearts are most similar to the human heart. This made it possible to map the metabolic changes following a heart attack in detail. Among other things, the study revealed the parts of the heart muscle which recovered after the infarction. The new MRI method could become an important step towards personalized medicine. The researchers hope that the innovative procedure will also help physicians understand why certain people have much greater impairment after a heart attack than others. However, the method has to prove itself in larger clinical studies in the coming years. To this end, the researchers will further refine the technology of the prototype “fridge”. The researchers have also launched their first clinical trial in which patients with heart failure or risk factors for heart failure will be examined.

“For us physicians, it’s very valuable to map the metabolism of the heart. In the future, this could enable us to improve diagnoses and prognoses of heart disease – and thus to tailor treatment more closely to the individual,” said Professor Robert Manka, Director of Cardiac MRI at the Heart Center of University Hospital Zurich. “Metabolism probably plays a role in this, but we don’t know it yet. In the future, we’ll be able to see what’s really going on in the heart muscle and its cells.”

Related Links:
ETH Zurich
University of Zurich


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Premium Air-Mattress
MA-51
PACS Workstation
PaxeraView PRO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.